Observational study to investigate the intraocular pressure reduction effect by 0.4% Ripasudil after trabectome
Phase of Trial: Phase II
Latest Information Update: 10 Jan 2019
At a glance
- Drugs Ripasudil (Primary)
- Indications Glaucoma
- Focus Therapeutic Use
- 04 Jan 2019 Status changed from active, no longer recruiting to completed.
- 08 Jul 2018 Status changed from not yet recruiting to active, no longer recruiting.
- 11 Jul 2017 New trial record